Healthcare -
Biotechnology - NASDAQ - CH
$ 44.04
0.273 %
$ 3.78 B
Market Cap
-10.15
P/E
CRSP - STOCK-BASED COMPENSATION
Stock-based Compensation CRSP - CRISPR Therapeutics AG
86.6 M
LAST VALUE
-5.99%
2 YEAR CAGR
14.46%
5 YEAR CAGR
62.01%
10 YEAR CAGR